101 related articles for article (PubMed ID: 8849851)
41. Effects of enamel matrix derivative on Porphyromonas gingivalis.
Newman SA; Coscia SA; Jotwani R; Iacono VJ; Cutler CW
J Periodontol; 2003 Aug; 74(8):1191-5. PubMed ID: 14514233
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the antibacterial activity of an ozonated oil with chlorhexidine digluconate and povidone-iodine. A disk diffusion test.
Montevecchi M; Dorigo A; Cricca M; Checchi L
New Microbiol; 2013 Jul; 36(3):289-302. PubMed ID: 23912871
[TBL] [Abstract][Full Text] [Related]
43. Black tea theaflavins attenuate Porphyromonas gingivalis virulence properties, modulate gingival keratinocyte tight junction integrity and exert anti-inflammatory activity.
Ben Lagha A; Grenier D
J Periodontal Res; 2017 Jun; 52(3):458-470. PubMed ID: 27549582
[TBL] [Abstract][Full Text] [Related]
44. Removing bacteria from rough surface titanium discs with chlorhexidine and additional brushing with dentifrice.
Park JB; Koh M; Jang YJ; Choi BK; Kim KK; Ko Y
Gerodontology; 2016 Mar; 33(1):28-35. PubMed ID: 24417576
[TBL] [Abstract][Full Text] [Related]
45. Identification of glyceraldehyde-3-phosphate dehydrogenase of epithelial cells as a second molecule that binds to Porphyromonas gingivalis fimbriae.
Sojar HT; Genco RJ
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):25-30. PubMed ID: 15985219
[TBL] [Abstract][Full Text] [Related]
46. Peptide-modified nanoparticles inhibit formation of
Kalia P; Jain A; Radha Krishnan R; Demuth DR; Steinbach-Rankins JM
Int J Nanomedicine; 2017; 12():4553-4562. PubMed ID: 28790818
[TBL] [Abstract][Full Text] [Related]
47. Topographic distribution of black-pigmenting anaerobes before and after periodontal treatment by local delivery of tetracycline.
Mombelli A; Tonetti M; Lehmann B; Lang NP
J Clin Periodontol; 1996 Oct; 23(10):906-13. PubMed ID: 8915018
[TBL] [Abstract][Full Text] [Related]
48. Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation.
Daep CA; James DM; Lamont RJ; Demuth DR
Infect Immun; 2006 Oct; 74(10):5756-62. PubMed ID: 16988253
[TBL] [Abstract][Full Text] [Related]
49. Role of Porphyromonas gingivalis 40-kDa outer membrane protein in the aggregation of P. gingivalis vesicles and Actinomyces viscosus.
Hiratsuka K; Abiko Y; Hayakawa M; Ito T; Sasahara H; Takiguchi H
Arch Oral Biol; 1992 Sep; 37(9):717-24. PubMed ID: 1329700
[TBL] [Abstract][Full Text] [Related]
50. Demonstration of adherence properties of Porphyromonas gingivalis outer membrane vesicles using a new microassay.
Duchesne P; Grenier D; Mayrand D
Oral Microbiol Immunol; 1995 Apr; 10(2):76-80. PubMed ID: 7675522
[TBL] [Abstract][Full Text] [Related]
51. Localization of the Fusobacterium nucleatum T18 adhesin activity mediating coaggregation with Porphyromonas gingivalis T22.
Kinder SA; Holt SC
J Bacteriol; 1993 Feb; 175(3):840-50. PubMed ID: 8380804
[TBL] [Abstract][Full Text] [Related]
52. Reduction of proteolytic degradation by chlorhexidine.
Grenier D
J Dent Res; 1993 Mar; 72(3):630-3. PubMed ID: 8383711
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of hemagglutinating activity by monoclonal antibody against Porphyromonas gingivalis 40-kDa outer membrane protein.
Tagawa H; Kiyama-Kishikawa M; Lee SY; Abiko Y
Hybrid Hybridomics; 2004 Jun; 23(3):183-6. PubMed ID: 15312309
[TBL] [Abstract][Full Text] [Related]
54. Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens.
Yang LC; Hu SW; Yan M; Yang JJ; Tsou SH; Lin YY
J Periodontol; 2015 Feb; 86(2):310-8. PubMed ID: 25345340
[TBL] [Abstract][Full Text] [Related]
55. A comparative evaluation of the antibacterial efficacy of honey in vitro and antiplaque efficacy in a 4-day plaque regrowth model in vivo: preliminary results.
Aparna S; Srirangarajan S; Malgi V; Setlur KP; Shashidhar R; Setty S; Thakur S
J Periodontol; 2012 Sep; 83(9):1116-21. PubMed ID: 22309178
[TBL] [Abstract][Full Text] [Related]
56. Effects of oral implant surface roughness on bacterial biofilm formation and treatment efficacy.
Lin HY; Liu Y; Wismeijer D; Crielaard W; Deng DM
Int J Oral Maxillofac Implants; 2013; 28(5):1226-31. PubMed ID: 24066312
[TBL] [Abstract][Full Text] [Related]
57. Novel antimicrobial peptide specifically active against Porphyromonas gingivalis.
Suwandecha T; Srichana T; Balekar N; Nakpheng T; Pangsomboon K
Arch Microbiol; 2015 Sep; 197(7):899-909. PubMed ID: 26041027
[TBL] [Abstract][Full Text] [Related]
58. Construction of recombinant hemagglutinin derived from the gingipain-encoding gene of Porphyromonas gingivalis, identification of its target protein on erythrocytes, and inhibition of hemagglutination by an interdomain regional peptide.
Sakai E; Naito M; Sato K; Hotokezaka H; Kadowaki T; Kamaguchi A; Yamamoto K; Okamoto K; Nakayama K
J Bacteriol; 2007 Jun; 189(11):3977-86. PubMed ID: 17384191
[TBL] [Abstract][Full Text] [Related]
59. The short-term effects of various oral care methods in dependent elderly: comparison between toothbrushing, tongue cleaning with sponge brush and wiping on oral mucous membrane by chlorhexidine.
Tashiro K; Katoh T; Yoshinari N; Hirai K; Andoh N; Makii K; Matsuo K; Ogasawara T
Gerodontology; 2012 Jun; 29(2):e870-82. PubMed ID: 22126396
[TBL] [Abstract][Full Text] [Related]
60. Three types of binding by Porphyromonas gingivalis and oral bacteria to fibronectin, buccal epithelial cells and erythrocytes.
Isogai E; Hirose K; Fujii N; Isogai H
Arch Oral Biol; 1992 Aug; 37(8):667-70. PubMed ID: 1355338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
